Bharat Parenterals Ltd — Dividend/Bonus, 12-05-2025: Corp. Action

Bharat Parenterals Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company declared a final dividend of Rs. 1.00 per equity share. The Board approved audited standalone and consolidated financial statements with unmodified audit opinions. The company acquired 99.85 lakh shares in subsidiary Innoxel Lifesciences Pvt Ltd for Rs. 64.81 Cr and completed a 100% acquisition of Varenyam Healthcare Pvt Ltd through share swap, recognizing goodwill of Rs. 52.10 Cr. Further, it acquired 40% stake in Varenyam Biolifesciences Pvt Ltd via share swap. Revenue and profitability rose, with standalone net profit at Rs. 26.45 Cr and consolidated loss at Rs. 43.68 Cr, impacted by acquisition-related expenses and goodwill. The company re-appointed Shah Mehta & Bakshi as auditors and recommended M/s. Jigar Trivedi & Co. as Secretarial Auditors for five years. Share capital increased to Rs. 68.9 Cr from Rs. 58.2 Cr.